Ilhomjon Butabekov

4 ta ish

Republican Specialized Scientific-Practical Medical Center of Phthisiology and Pulmonology, Tashkent, Uzbekistan

1. Treatment of multidrug-resistant tuberculosis in Uzbekistan from 2012 to 2018: does practice follow policy?

   Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +8

   MaqolaTuberculosis Research and Epidemiology20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.010203

2. The impact of the COVID-19 pandemic on tuberculosis detection in Tashkent, Uzbekistan

   Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6

   MaqolaDiverse Scientific Research Studies20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.011428

3. How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial

   Ilaria Motta, Martina Cusinato, Andrew Ludman +15

   MaqolaCardiac electrophysiology and arrhythmiasAntimicrobial Agents and Chemotherapy20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.000869

4. The effectiveness of pulmonary tuberculosis treatment during the COVID-19 pandemic

   Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6

   MaqolaCOVID-19 Prevention and Impact20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.008693